New funding for a research project focusing on CF rare genetic mutations
Génome Quebec and Cystic Fibrosis Canada funding for project to develop genetic therapy for CV patients with rare mutations.
News
Respiratory Research News from the Meakins-Christie Laboratories and the RESP program of the RI-MUHC. View our latest funding results, faculty and trainee awards, and our research featured in the media.
PAP Therapy Shows Promise for Improving Cognitive Function in Parkinson’s Disease
New study by Marta Kaminska shows PAP therapy improves cognitive function in Parkinson’s Disease
Darcy Wagner Awarded Prestigious JPND Grant
Darcy Wagner awarded a prestigious grant from the EU Joint Programme – Neurodegenerative Disease Research (JPND).
King Charles III Coronation Medal Awarded to RESP Members
Jean Bourbeau and Larry Lands receive the King Charles III Coronation Medal for their outstanding contributions to Lung Health.
Beta-glucan can ‘Reprogram’ Immune Cells With Promising Results
A study by Maziar Divangahi found that beta-glucan, a component in all fungi, can protect against flu-related lung damage.
CIHR Project Grant Results – Fall 2024
Congratulations to all RESP members who were funded in the Fall 2024 CIHR Project Grant Competition!
Promising New Treatment to Prevent Multidrug-Resistant Tuberculosis
Dick Menzies, Andrea Benedetti, and colleagues show that the antibiotic levofloxacin could significantly reduce the risk of MDR-TB.
Wearables: A Game Changer for COPD Care
New study by Bryan Ross shows how wearable technologies can revolutionize the management of COPD
Gut Fungus: A Hidden Ally in Fighting Parasites
Work by Irah King has uncovered a previously unknown role of fungi in shaping intestinal immunity.
The Institute is a Leader in Health Research
The MUHC, and its affiliated research Institute, ranks as Quebec’s top research hospital